Rosetta Partners Limited
- Company number
- 16067520
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 8 Nov 2024
- Nature of business
- Activities of other holding companies n.e.c.
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HEPPLE, Jonathan Paul, Dr | Director | 8 Nov 2024 | |
| FORER, Michael | Director | 8 Nov 2024 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Jonathan Paul Hepple | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
8 Nov 2024 | |
| Mr Michael Forer | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
8 Nov 2024 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | £97,783 | £19,190 | 0 |
Connections
Controls
- Rosetta Capital Viii Gp LP (SL037555)
- Rosetta Capital Viii Participation Partners LP (SL037568)
Directors’ other companies
- HEPPLE, Jonathan Paul, Dr - Director at Rosetta Capital V Gp Limited
- HEPPLE, Jonathan Paul, Dr - Director at Nucleome Therapeutics Limited
Companies at the same address
- Rosetta Capital Vii LP (LP022966)
- Rosetta Capital Viii, LP (LP024684)